| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 12/27/2001 | US20010056107 Cyano and carboxy derivatives of substituted styrenes are inhibitors of tumor necrosis factor alpha , nuclear factor kappa B, and phosphodiesterase and can be used to treat cachexia, endotoxic shock, inflammatory conditions etc. |
| 12/27/2001 | US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 12/27/2001 | US20010055777 Potentiation of the immune response |
| 12/27/2001 | CA2805216A1 Antigenic polypeptides from staphylococcus |
| 12/27/2001 | CA2713965A1 Glycopeptide phosphonate derivatives |
| 12/27/2001 | CA2414085A1 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/27/2001 | CA2414010A1 Secreted redox proteins |
| 12/27/2001 | CA2413959A1 Fusion proteins of mycobacterium tuberculosis |
| 12/27/2001 | CA2413866A1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 12/27/2001 | CA2413830A1 Peptide and polypeptide inhibitors of complement c1s |
| 12/27/2001 | CA2413554A1 Biotransformation of biologically active compounds made of various classes of chemical substances by means of laccase and manganese peroxidase enzymes |
| 12/27/2001 | CA2413454A1 A g-protein coupled receptor |
| 12/27/2001 | CA2413450A1 Streptococcus antigens |
| 12/27/2001 | CA2413435A1 A recombinant cell line expressing gpcrx11 as a functional receptor validated by angiopeptin and useful for screening of agonists and antagonists |
| 12/27/2001 | CA2413421A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413418A1 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413331A1 Use of phyllanthus constituents for treating or preventing infections caused by flaviviridae |
| 12/27/2001 | CA2413284A1 Use of c4-c10 acids for preventing gram-negative bacterial infections |
| 12/27/2001 | CA2413274A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2412985A1 Hiv integrase inhibitors |
| 12/27/2001 | CA2412905A1 Improved injectable dispersions of propofol |
| 12/27/2001 | CA2412484A1 G-protein coupled receptors |
| 12/27/2001 | CA2412011A1 Chemically-modified antimicrobial peptides, compositions and methods of production and use |
| 12/27/2001 | CA2411945A1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor |
| 12/27/2001 | CA2411912A1 Compositions and methods for treatment of candidiasis |
| 12/27/2001 | CA2411865A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 12/27/2001 | CA2411857A1 Peptides, compositions and methods for the treatment of burkholderia cepacia |
| 12/27/2001 | CA2411585A1 Novel non-psychotropic cannabinoids |
| 12/27/2001 | CA2411100A1 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
| 12/27/2001 | CA2410632A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 12/27/2001 | CA2410452A1 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 12/27/2001 | CA2410358A1 A thiazine oxazolidinone |
| 12/27/2001 | CA2410208A1 Systems and methods for treating a mucosal surface |
| 12/27/2001 | CA2409778A1 Secreted proteins |
| 12/27/2001 | CA2409776A1 G-protein coupled receptors |
| 12/27/2001 | CA2407896A1 Medium chain fatty acids applicable as antimicrobial agents |
| 12/26/2001 | CN1328565A Antiviral purine derivatives |
| 12/26/2001 | CN1328563A Organophosphorous compounds and use thereof |
| 12/26/2001 | CN1328558A Crystal modification A of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-chinolincarboxylique |
| 12/26/2001 | CN1328557A Semi-hydrochloride of 8-cyan-1-cyclopropyl-7-(1S-2,8-diazabicyclo [4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid |
| 12/26/2001 | CN1328556A Crystal modification B of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid |
| 12/26/2001 | CN1328546A Pyrrolidines as inhibitors of neuraminidases |
| 12/26/2001 | CN1328466A Use of antifungal agents for treating scleroses |
| 12/26/2001 | CN1328465A Use of phosphonoformic acid derivatives for treating infections |
| 12/26/2001 | CN1328464A Use of phosphonoformic acid derivatives for treating infections |
| 12/26/2001 | CN1328463A Use of 17-ketosteroid compounds, as well as derivatives, metabolites and precursors for treatment of hapatitis C type virus and other togavirus infections |
| 12/26/2001 | CN1328457A Use of N-substituted-1,5-dideoxy -1,5-imino-D-glucitol compounds for treating hepatitis virus |
| 12/26/2001 | CN1327976A Benzoxazinone compounds asymmetrically synthesized from new intermediate |
| 12/26/2001 | CN1327853A Stable alpha-interferon preparation |
| 12/26/2001 | CN1327849A Composite Chinese medicine for treating lung diseases |
| 12/26/2001 | CN1327836A Instant particles as Chinese medicine for treating AIDS and its preparing process |
| 12/26/2001 | CN1327834A Oral liquid for removing endogenous heat |
| 12/26/2001 | CN1327831A Chinese medicine for treating tinea and antipruritic |
| 12/26/2001 | CN1327827A Exterior-applied medicine for treating dermatopathy |
| 12/26/2001 | CN1327810A Exterior-applied medicine for treating dermatopathy |
| 12/26/2001 | CN1327799A Mixture of white pepper and borneol and its application |
| 12/26/2001 | CN1327794A Vaginal minocycline suppository |
| 12/26/2001 | CN1327793A Pyrrolo-triazine and pyrimidine compounds |
| 12/26/2001 | CN1076586C Mucosal competitive exclosion flora |
| 12/26/2001 | CA2350043A1 Novel melanocortin -4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
| 12/25/2001 | US6333410 Process for the preparation and purification of thiol-containing maytansinoids |
| 12/25/2001 | US6333402 For therapy and diagnosis |
| 12/25/2001 | US6333395 Exhibit anti-membrane fusion capability, antiviral activity, such as the ability to inhibit hiv transmission to uninfected cells |
| 12/25/2001 | US6333344 Prolines as antimicrobial agents |
| 12/25/2001 | US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics |
| 12/25/2001 | US6333319 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 12/25/2001 | US6333315 4′-C-ethynyl purine nucleoside compounds |
| 12/25/2001 | US6333311 Has inflammatory and immune response functions such as regulation of monocyte colony stimulating factor synthesis, regulation of interleukin synthesis, activation of natural killer cell activity, inhibition of metastasis |
| 12/25/2001 | US6333305 For therapy of fungal infections |
| 12/25/2001 | US6333171 CD4 gene regulatory sequences specifically expressed in mature T cells |
| 12/25/2001 | US6333036 Vaccine composition containing polyribosylribitol phosphate and method for making same |
| 12/25/2001 | CA2234164C Novel orthosomycins from micromonospora carbonacea |
| 12/25/2001 | CA2139385C Products containing g-csf and tnf binding protein |
| 12/25/2001 | CA2058592C Antibacterial agents |
| 12/22/2001 | CA2312252A1 5,6,7-trinor-4, 8-inter-m-phenylene pgi2 derivative and medicine containing the same |
| 12/20/2001 | WO2001096611A1 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 12/20/2001 | WO2001096603A2 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 12/20/2001 | WO2001096586A1 Antisense modulation of c/ebp alpha expression |
| 12/20/2001 | WO2001096565A2 Binding agents: chimeric ligand/receptor proteins |
| 12/20/2001 | WO2001096558A1 Polyfunctional base sequence and artificial gene containing the same |
| 12/20/2001 | WO2001096547A2 Human kinases |
| 12/20/2001 | WO2001096546A2 Protein phosphatases |
| 12/20/2001 | WO2001096540A2 Hepatitis c protease exosite for inhibitor design |
| 12/20/2001 | WO2001096397A2 Cd154 variants and uses thereof |
| 12/20/2001 | WO2001096381A2 IMMUNIZATION OF DAIRY CATTLE WITH GapC PROTEIN AGAINST STREPTOCOCCUS INFECTION |
| 12/20/2001 | WO2001096379A2 Immunization of dairy cattle with chimeric gapc protein against streptococcus infection |
| 12/20/2001 | WO2001096377A2 Vaccine for congenital tremors in pigs |
| 12/20/2001 | WO2001096376A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 12/20/2001 | WO2001096368A2 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 12/20/2001 | WO2001096354A1 Combinatorial production of nucleotide and nucleoside (xitp)analogues |
| 12/20/2001 | WO2001096353A2 3'-PRODRUGS OF 2'-DEOXY-β-L-NUCLEOSIDES |
| 12/20/2001 | WO2001096347A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD |
| 12/20/2001 | WO2001096343A1 Substituted metal-phthalocyanines, their preparation and the use thereof |
| 12/20/2001 | WO2001096338A1 Non-nucleoside reverse transcriptase inhibitors |
| 12/20/2001 | WO2001096322A1 Diamino phenothiazine derivatives and composition comprising same |
| 12/20/2001 | WO2001096311A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 12/20/2001 | WO2001096310A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists |
| 12/20/2001 | WO2001096305A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096300A1 Growth hormone secretagogues |
| 12/20/2001 | WO2001096297A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |